KDELR3 Is a Prognostic Biomarker Related to the Immune Infiltration and Chemoresistance of Anticancer Drugs in Uveal Melanoma

Table 3

Univariate and multivariate analyses of the associations of progression-free survival with various clinicopathologic parameters and KDELR3 expression in uveal melanoma patients.

Characteristics	Total ()	Univariate analysis		Multivariate analysis
		Hazard ratio (95% CI)	value	Hazard ratio (95% CI)	value
Pathologic T stage	80
T2	14	Reference
T3	32	2.512 (0.314-20.124)	0.386
T4	34	4.433 (0.572-34.338)	0.154
Pathologic N stage	79
N0	52	Reference
NX	27	0.985 (0.391-2.483)	0.974
Pathologic M stage	78
M0	51	Reference
M1 and MX	27	1.024 (0.405-2.585)	0.961
Pathologic stage	79
Stage II	39	Reference
Stage III and stage IV	40	1.607 (0.640-4.033)	0.312
Age	80
≤60	40	Reference
>60	40	1.872 (0.785-4.461)	0.157
Gender	80
Female	35	Reference
Male	45	1.351 (0.558-3.275)	0.505
KDELR3	80
Low	40	Reference
High	40	17.116 (3.961-73.971)	<0.001	17.116 (3.961-73.971)	<0.001